HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

Jun 2021| TBR796C| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrase strand transfer inhibitors (INSTIs); Others
2) By Application: Hospital Pharmacies; Retail Pharmacies; Others
3) By Administration: Oral; Parenteral
Covering: Gilead Sciences, Inc.; GlaxoSmithKline plc.; Johnson & Johnson; Merck & Co., Inc.; Boehringer Ingelheim International GmbH

HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global HIV drugs market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Description:
Where is the largest and fastest growing market for the HIV drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The HIV Drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider HIV drugs market, and compares it with other markets.

The report covers the following chapters

  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction – The introduction section of the report gives brief introduction about segmentation by geography, segmentation by type, by application, by administration.
  • Market Characteristics – The market characteristics section of the report defines and explains the HIV drugs market. This chapter also defines and describes goods and related services covered in the report.
  • Trends And Strategies – This chapter describes the major trends shaping the global HIV drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of CoVID-19 – This section describes the impact of COVID-19 on the HIV drugs market.
  • Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape – This section covers details on the competitive landscape of the global HIV drugs market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for HIV drug companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrase strand transfer inhibitors (INSTIs); Others
2) By Application: Hospital Pharmacies; Retail Pharmacies; Others
3) By Administration: Oral; Parenteral

Companies Mentioned: Gilead Sciences, Inc.; GlaxoSmithKline plc.; Johnson & Johnson; Merck & Co., Inc.; Boehringer Ingelheim International GmbH

Metrics Covered: Number of Enterprises; Number of Employees

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; UK; Germany; France; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, HIV drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

  • Table 1 : Global HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 2 : Global HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 3 : Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 4 : Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 5 : Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 6 : Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 7 : Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 8 : Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 9 : Global HIV Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 10 : Global HIV Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 11 : Global HIV Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 12 : Global HIV Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 13 : Asia Pacific Population By Age Group, 2015-2025, Thousands
  • Table 14 : Asia-Pacific Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 15 : Asia Pacific GDP Per Capita, 2015-2019, $
  • Table 16 : Asia Pacific HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 17 : Asia-Pacific HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 18 : Asia-Pacific HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 19 : Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 20 : Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 21 : China Population By Age Group, 2015-2025, Thousands
  • Table 22 : China Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 23 : China GDP Per Capita, 2015-2019, $
  • Table 24 : China HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 25 : China HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 26 : China HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 27 : China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 28 : China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 29 : India HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 30 : India HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 31 : India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 32 : India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 33 : Japan HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 34 : Japan HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 35 : Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 36 : Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 37 : Australia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 38 : Australia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 39 : Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 40 : Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 41 : Indonesia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 42 : Indonesia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 43 : Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 44 : Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 45 : South Korea HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 46 : South Korea HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 47 : South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 48 : South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 49 : Western Europe Population By Age Group, 2015-2025, Thousands
  • Table 50 : Western Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 51 : Western Europe GDP Per Capita, 2015-2019, $
  • Table 52 : Western Europe HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 53 : Western Europe HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 54 : Western Europe HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 55 : Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 56 : Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 57 : UK HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 58 : UK HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 59 : UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 60 : UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 61 : Germany HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 62 : Germany HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 63 : Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 64 : Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 65 : France HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 66 : France HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 67 : France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 68 : France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 69 : Eastern Europe Population By Age Group, 2015-2025, Thousands
  • Table 70 : Eastern Europe Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 71 : Eastern Europe GDP Per Capita, 2015-2019, $
  • Table 72 : Eastern Europe HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 73 : Eastern Europe HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 74 : Eastern Europe HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 75 : Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 76 : Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 77 : Russia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 78 : Russia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 79 : Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 80 : Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 81 : North America Population By Age Group, 2015-2025, Thousands
  • Table 82 : North America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 83 : North America GDP Per Capita, 2015-2019, $
  • Table 84 : North America HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 85 : North America HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 86 : North America HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 87 : North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 88 : North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 89 : USA Population By Age Group, 2015-2025, Thousands
  • Table 90 : USA Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 91 : USA GDP Per Capita, 2015-2019, $
  • Table 92 : USA HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 93 : USA HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 94 : USA HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 95 : USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 96 : USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 97 : South America Population By Age Group, 2015-2025, Thousands
  • Table 98 : South America Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 99 : South America GDP Per Capita, 2015-2019, $
  • Table 100 : South America HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 101 : South America HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 102 : South America HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 103 : South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 104 : South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 105 : Brazil HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 106 : Brazil HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 107 : Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 108 : Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 109 : Middle East Population By Age Group, 2015-2025, Thousands
  • Table 110 : Middle East Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 111 : Middle East GDP Per Capita, 2015-2019, $
  • Table 112 : Middle East HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 113 : Middle East HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 114 : Middle East HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 115 : Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 116 : Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 117 : Africa Population By Age Group, 2015-2025, Thousands
  • Table 118 : Africa Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 119 : Africa GDP Per Capita, 2015-2019, $
  • Table 120 : Africa HIV Disease Prevalence, 2015-2019, Number Of Patients
  • Table 121 : Africa HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Table 122 : Africa HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Table 123 : Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Table 124 : Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, $ Million
  • Table 125 : Global HIV Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 126 : Gilead Sciences, Inc. - Financial Performance, 2015 - 2019, $ Billion
  • Table 127 : GlaxoSmithKline Plc. - Financial Performance, 2015 - 2019, $ Billion
  • Table 128 : Johnson & Johnson (J&J) - Financial Performance, 2015 - 2019, $ Billion
  • Table 129 : Merck & Co. - Financial Performance, 2015-2019, $ Billion
  • Table 130 : Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion
  • Table 131 : Global HIV Drugs Market Size Gain ($ Million), 2020 - 2025, By Country
  • Table 132 : Global HIV Drugs Market Size Gain ($ Million), Segmentation By Type, 2020 - 2025
  • Table 133 : Global HIV Drugs Market Size Gain ($ Million), Segmentation By Application, 2020 - 2025
  • Table 134 : Global HIV Drugs Market Size Gain ($ Million), Segmentation By Administration, 2020 - 2025
  • Table 135 : HIV Drugs - Market Data Sources
  • Figure 1 : Global HIV Drugs Market Segmentation By Type
  • Figure 2 : Global HIV Drugs Market Segmentation By Application
  • Figure 3 : Global HIV Drugs Market Segmentation By Administration
  • Figure 4 : Global HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 5 : Global HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 6 : Global HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 7 : Global HIV Drugs Market, Segmentation By Application, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 8 : Global HIV Drugs Market, Segmentation By Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 9 : Global HIV Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 10 : Global HIV Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 11 : Asia-Pacific HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 12 : Asia-Pacific HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 13 : Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 14 : China HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 15 : China HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 16 : China HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 17 : India HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 18 : India HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 19 : India HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 20 : Japan HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 21 : Japan HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 22 : Japan HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 23 : Australia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 24 : Australia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 25 : Australia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 26 : Indonesia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 27 : Indonesia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 28 : Indonesia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 29 : South Korea HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 30 : South Korea HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 31 : South Korea HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 32 : Western Europe HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 33 : Western Europe HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 34 : Western Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 35 : UK HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 36 : UK HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 37 : UK HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 38 : Germany HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 39 : Germany HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 40 : Germany HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 41 : France HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 42 : France HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 43 : France HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 44 : Eastern Europe HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 45 : Eastern Europe HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 46 : Eastern Europe HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 47 : Russia HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 48 : Russia HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 49 : Russia HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 50 : North America HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 51 : North America HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 52 : North America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 53 : USA HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 54 : USA HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 55 : USA HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 56 : South America HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 57 : South America HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 58 : South America HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 59 : Brazil HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 60 : Brazil HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 61 : Brazil HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 62 : Middle East HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 63 : Middle East HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 64 : Middle East HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 65 : Africa HIV Drugs Market, Historic, 2015 - 2020, $ Million
  • Figure 66 : Africa HIV Drugs Market, Forecast, 2020 - 2025, 2030F, $ Million
  • Figure 67 : Africa HIV Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, %
  • Figure 68 : Global HIV Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 69 : Gilead Sciences, Inc. - Financial Performance, 2015 - 2019, $ Billion
  • Figure 70 : GlaxoSmithKline Plc. - Financial Performance, 2015 - 2019, $ Billion
  • Figure 71 : Johnson & Johnson (J&J) - Financial Performance, 2015 - 2019, $ Billion
  • Figure 72 : Merck & Co. - Financial Performance, 2015-2019, $ Billion
  • Figure 73 : Boehringer Ingelheim GmbH - Financial Performance, 2015 - 2019, $ Billion

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report